Home Institutions UT Southwestern Medical Center clinical trials Institution Directory
Clinical trials at UT Southwestern Medical Center Sites in Dallas, TX
Institution pages show live ClinicalTrials.gov records that list this campus as a study site, whoever sponsors them. They do not rate, rank, or describe the institution.
ClinicalTrials.gov public records Last synced Oct 31, 2026, 12:09 PM EDT
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official matching trials
1262
Current sort
Recently updated
Campus scope
UT Southwestern Medical Center, Dallas, TX
Additional filters apply within this campus.
These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.
Showing 625–636 of 1,262 matching trials with a site at UT Southwestern Medical Center, Dallas, TX.
Live ClinicalTrials.gov results.
Local aggregate panels are unavailable or hidden for filtered views. The result list above identifies its data source.
Live official records
Conditions B-cell Acute Lymphoblastic Leukemia, Obesity
Interventions IDEAL2 Intervention Behavioral
Lead sponsor Etan Orgel Other
Eligibility 7 Years to 25 Years
Enrollment 240 participants
Healthy volunteers Healthy volunteers not accepted
Timeline 2022 – 2032
U.S. locations 16
States / cities Los Angeles, California • Orange, California • San Francisco, California + 13 more
Conditions Coronary Artery Disease
Interventions Not listed
Lead sponsor Minneapolis Heart Institute Foundation Other
Eligibility Not listed
Enrollment 2,000 participants
Healthy volunteers Healthy volunteers not accepted
Timeline 2012 – 2030
U.S. locations 42
States / cities Phoenix, Arizona • Little Rock, Arkansas • San Diego, California + 31 more
Conditions Cystic Fibrosis
Interventions RCT2100, Placebo, Ivacaftor Drug · Other
Lead sponsor ReCode Therapeutics Industry
Eligibility 18 Years to 60 Years
Enrollment 128 participants
Healthy volunteers Accepts healthy volunteers
Timeline 2024 – 2026
U.S. locations 13
States / cities Birmingham, Alabama • Tucson, Arizona • Palo Alto, California + 10 more
Conditions LAMA2-MD \(Merosin Deficient Congenital Muscular Dystrophy, MDC1A\)
Interventions Not listed
Lead sponsor Nationwide Children's Hospital Other
Eligibility Up to 5 Years
Enrollment 44 participants
Healthy volunteers Healthy volunteers not accepted
Timeline 2025 – 2028
U.S. locations 14
States / cities Los Angeles, California • Stanford, California • Chicago, Illinois + 11 more
Conditions Recurrent World Health Organization (WHO) Grade II Glioma, Low-grade Glioma, High-Grade Glioma (HGG)
Interventions Everolimus, Trametinib Drug
Lead sponsor University of California, San Francisco Other
Eligibility 1 Year to 25 Years
Enrollment 50 participants
Healthy volunteers Healthy volunteers not accepted
Timeline 2020 – 2027
U.S. locations 17
States / cities Birmingham, Alabama • Los Angeles, California • San Diego, California + 14 more
Conditions Pediatric, Symptomatic Obstructive Hypertrophic Cardiomyopathy
Interventions Aficamten, Placebo Drug
Lead sponsor Cytokinetics Industry
Eligibility 12 Years to 17 Years
Enrollment 65 participants
Healthy volunteers Healthy volunteers not accepted
Timeline 2024 – 2030
U.S. locations 24
States / cities Phoenix, Arizona • Little Rock, Arkansas • Los Angeles, California + 20 more
Conditions Progressive Pulmonary Fibrosis, Interstitial Lung Disease
Interventions Not listed
Lead sponsor University of Massachusetts, Worcester Other
Eligibility 18 Years to 80 Years
Enrollment 500 participants
Healthy volunteers Healthy volunteers not accepted
Timeline 2025 – 2029
U.S. locations 7
States / cities Aurora, Colorado • Worcester, Massachusetts • Ann Arbor, Michigan + 4 more
Conditions Prostate Adenocarcinoma
Interventions Bicalutamide, Buserelin, Darolutamide, Degarelix, Flutamide, Goserelin, Histrelin, Leuprolide, Radiation Therapy, Relugolix, Triptorelin Drug · Radiation
Lead sponsor NRG Oncology Other
Eligibility 18 Years and older · Male only
Enrollment 2,050 participants
Healthy volunteers Healthy volunteers not accepted
Timeline 2021 – 2031
U.S. locations 567
States / cities Birmingham, Alabama • Gilbert, Arizona • Peoria, Arizona + 432 more
Conditions Small Cell Lung Cancer
Interventions Alisertib Drug
Lead sponsor Puma Biotechnology, Inc. Industry
Eligibility 18 Years and older
Enrollment 120 participants
Healthy volunteers Healthy volunteers not accepted
Timeline 2024 – 2028
U.S. locations 30
States / cities Daphne, Alabama • Long Beach, California • Lone Tree, Colorado + 24 more
Conditions Glioblastoma, Gliosarcoma
Interventions Lomustine, Magnetic Resonance Imaging, Photon Beam Radiation Therapy, Questionnaire Administration, Temozolomide Drug · Procedure · Radiation + 1 more
Lead sponsor NRG Oncology Other
Eligibility 18 Years to 70 Years
Enrollment 265 participants
Healthy volunteers Healthy volunteers not accepted
Timeline 2022 – 2031
U.S. locations 418
States / cities Fairbanks, Alaska • Fayetteville, Arkansas • Little Rock, Arkansas + 304 more
Conditions Small Cell Lung Cancer Extensive Stage, Brain Metastases, Solid Tumor, Adult, Thoracic Cancer, Sarcoma,Soft Tissue, HNPCC
Interventions Cohort A: Extensive Stage Small Cell Lung Cancer (ES-SCLC) Thoracic Tumor PULSAR (Personalized ultrahypofractionated stereotactic ablative radiotherapy), Cohort B: Brain metastasis PULSAR (Personalized ultrahypofractionated stereotactic ablative radiotherapy), Cohort C: Sarcoma Pre-Operative PULSAR, Cohort D: Resectable Head & Neck Squamous Cell Carcinoma (HNSCC) PULSAR/SAbR Radiation
Lead sponsor University of Texas Southwestern Medical Center Other
Eligibility 18 Years and older
Enrollment 105 participants
Healthy volunteers Healthy volunteers not accepted
Timeline 2025 – 2032
U.S. locations 1
States / cities Dallas, Texas
Conditions Metastatic Malignant Neoplasm in the Bone, Metastatic Malignant Solid Neoplasm
Interventions Best Practice, Biospecimen Collection, Bone Metastases Treatment, Computed Tomography, Conventional Radiotherapy, Magnetic Resonance Imaging, Patient Observation, Questionnaire Administration, Stereotactic Body Radiation Therapy Other · Procedure · Radiation
Lead sponsor NRG Oncology Other
Eligibility 18 Years and older
Enrollment 280 participants
Healthy volunteers Healthy volunteers not accepted
Timeline 2025 – 2034
U.S. locations 624
States / cities Fairbanks, Alaska • Gilbert, Arizona • Phoenix, Arizona + 450 more About this UT Southwestern Medical Center institution page
What this page lists ClinicalTrials.gov records that list UT Southwestern Medical Center in Dallas, TX as a study site, whoever sponsors them, among recruiting, not yet recruiting, and active not recruiting trials.
Site status A study's overall status can differ from this site's status. Sites marked withdrawn, terminated, or completed are not counted here. Each record shows the status listed for this site when the official record provides one.
Where the data comes from Records are sourced from the official ClinicalTrials.gov public API. Each result links back to the official study page, which is the source of truth for eligibility, enrollment, and contact information.
What this page does not do No medical advice, eligibility judgments, ranking of trials, or AI-generated medical summaries. This page does not rank or rate institutions.
Related: all institution pages , browse by condition , or browse by U.S. city .